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Introduction
Histamine (HA) (M = 111.1451 g.mol -1 ) had been discovered in 1910 by Dale and Laidlaw [1] . HA is a small organic nitrogenous molecule known to play an important role in allergic reactions. Indeed, mast cells and basophils are specifically prone to synthetize HA, and to secrete it after IgE-dependent activation and degranulation during type I hypersensitivity and/or H2R leads to vasodilatation, blood pressure diminution, mucus secretion, or even gastric acid secretion. Due to H3R ligation, HA plays a role in various neurological processes such as food intake or memory, and in neuropathology [2] . As described by Rosa and Fantozzi [3] , HA could play an important role in neurogenic inflammation, particularly in nociceptive pain but also in neurogenic inflammation of skin, airways and bladder. Finally, many findings confer to HA a physiologic role during pregnancy [4] [5] .
During type I hypersensitivity responses, only 2 biological markers seem relevant and are currently quantified in routine laboratories to validate the allergic reaction: HA and tryptase.
HA release could be measured in plasma, but also in other matrix such as urine [6] , cerebrospinal fluid [7] , or even cell culture supernatant [8] . Due to HA low concentrations in these different fluids even after an important release, sensitive quantification methods are needed. Various analytical methods have already been developed to identify and quantify HA in biological samples: liquid chromatography (LC) [9] [10], gas chromatography (GC) [11] [12], capillary electrophoresis (CE) [13] coupled with different detection modes. Derivatization was usually used to improve the sensitivity, but was time-consuming, and increased the risk of low analyte recovery. Other non-separative methods like radioimmunoassay (RIA) [14] [15] or enzyme immunoassays (EIA) [16] are currently the most common methods used in medical laboratories. RIA is yet considered as the gold standard method. However, RIA is highly time-consuming, and protective measures against radiations and exposure monitoring of the technicians due to use of radioactivity are necessary. In addition, cross reactivity with 3-methylhistamine, the main metabolite of HA in vivo, is still an issue for RIA and EIA methods [17] .
The definition of new methods combining high resolution and high throughput analyses could be useful. To our knowledge, no method using Liquid Chromatography -High ResolutionMass Spectrometry (LCHRMS) to quantify HA in plasma samples has been yet developed and validated for medical laboratory application. Herein, we describe a validated method using liquid chromatography coupled with an ultra-high resolution and accurate mass A C C E P T E D M A N U S C R I P T
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instrument (Q Exactive TM ) for HA quantification in plasma from patients suspected to develop an anaphylactic reaction. This method was compared to the RIA gold standard method, and was found to be routinely usable in medical laboratories.
Experimental

Chemicals and reagents
Histamine (HA) (C5H9N3), nonafluoropentanoic acid (NFPA), sulfosalycylic acid (SSA), trifluoroacetic acid (TFA), Tris, NaCl, KCl, CaCl2, MgCl2 and Bovine Serum Albumin (BSA)
were obtained from Sigma-Aldrich (St Quentin Fallavier, France). Acetonitrile (ACN) was obtained from Thermo Fisher (Elancourt, France). Deuterated Histamine (HAd4) (Histamine-α,α,β,β-d4), the internal standard (IS), was obtained from C/D/N Isotopes (Quebec, Canada).
TrisBSA solution was prepared as follow: 3.02859g of Tris, 7.0128g NaCl, 0.3728g KCl, 0.0445g CaCl2, 0.1016g MgCl2, and 0.3g BSA were dissolved in 1 litre of water. All chemicals, reagents and solvents were of LC/MS quality grade.
Instrumentation
Analyses were performed on a Thermo Scientific Q Exactive TM (San Jose, USA) mass spectrometer including an Accela pump (Thermo Scientific, San Jose, USA). A heated electrospray ionisation-II (HESI-II) ion source was used for the ionization of target compounds. Data acquisition, peak integration and calibration were performed using Xcalibur ® 2.1 software (ThermoScientific, San Jose, CA, USA).
LC conditions
LC separation was performed using a C18 Accucore column (100 mm*2.1, 2.6 μm) (ThermoScientific, San Jose, CA, USA) thermostated at 40°C. The mobile phases used were NFPA (3 mmol.L -1 ; solvent A) and ACN with 0.1% (v/v) formic acid (solvent B) in a mobile phase as described in Table 1 . All prepared samples were kept at 15°C in the auto-sampler until injection of 20μL into the LCHRMS system (full loop). Sampling needle was washed with a flush (75%ACN, 25% water containing 0.1% TFA).
MS conditions
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The source HESI-II was set up as follow: probe at 300°C was operated in positive electrospray ionization mode with spray voltage of 3kV, sheath gas and auxiliary gas (N2)
were pressurized at 40 psi and 10 arbitrary units respectively, capillary temperature was set at 300°C and source lens at 60V. Data were acquired simultaneously in full scan with highresolution acquisition and targeted MS2 modes. In full scan acquisition, resolution was set at 70000 FWHM. The C-trap capacity was set at 10 6 charges and the maximum injection time at
200ms. The mass range was set from 100 to 123 m/z. In targeted MS2 mode, resolution was set at 17500 FWHM. The C-trap capacity was set at 5. 
Quality Controls preparation
Quality control (QC) samples were prepared at three concentrations of HA (3, 30 and 150 nM)
by fortifying TrisBSA solution, and stored at -80°C. 100μL of QC was added to 250μL of deionized water and 100μL of IS. SSA (50μL at 20% v/v) was added in each tube for protein precipitation before vortexing for 30 seconds. After centrifugation at 3000g for 10 minutes at 4°C, 200μL of supernatant were transferred to an auto-sample vial.
Calibration and linearity
100μL of each calibration standard solution was added to 100μL of TrisBSA, 150μL of deionized water, 100μL of IS, and 50μL of SSA at 20% (v/v). After extraction, the six calibration points were analysed. Standard curves corresponded to peak area ratios of HA to IS using
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weighted linear least-squares regression (1/x), and coefficients of determination (r²) were calculated. Mean and standard deviation (SD) were calculated from six calibration curves run each day, and precision was represented by the coefficient of variation (CV=100*SD/mean) between each calibration point run 6 times.
Recovery, process efficiency and matrix effect
Recovery (RE), matrix effects (MEs), and process efficiency (PE) were performed in QC samples at 3 concentrations (3, 30 and 150 nM) in analogy to the simplified approach described by [18] et al . Briefly, RE was calculated by comparing average peak areas of
TrisBSA fortified by the same concentrations of QC samples, before or after the extraction procedure. PE was determined by comparing average peak areas of TrisBSA fortified prior to extraction with peak areas of samples at the same nominal concentrations prepared in water (neats). MEs were calculated as follows: (100 * mean peak area of fortified TrisBSA after extraction / mean peak area of neats) -100.
Precision and accuracy
The repeatability (intraday precision) was evaluated by analysing 6 different samples of each QC concentration (3, 30, 150 nM) in the same day. For reproducibility (interday precision), 10 different day analyses were assessed for the 3 QC samples. The calculated values were based on a daily calibration curve. Precision was calculated by using the coefficient of variation (CV % = (SD/M)*100); where M is the mean of the experimentally determined concentrations and SD the standard deviation of M and the bias was used to express accuracy [19] . The assay acceptance criterion for each concentration was ± 15% deviation of the nominal concentration, except for the lower limit of quantification (LLOQ) for which a deviation of ± 20% was accepted.
Stability
Long-term stability of stock solutions was evaluated by comparing stored and fresh stock solutions. Long-term stability of HA was checked by measuring QC samples (3, 30 , and 150 nM) stored at -80°C during 6 months using a daily calibration curve. The stability of HA after extraction was tested on the same extract injected at the beginning and at the end of an analytical run of 12 hours. This stability was checked at 3 levels (3, 30 and 150 nM) of spiked plasma.
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Method validation
Institutional review board approval was obtained for the use of human plasma samples, of supernatant were transferred to an auto-sample vial.
Statistical analysis
GraphPad Prism 5.0 (GraphPad Software, San Diego, CA, USA) and Excel software were used to perform statistical analyses. LCHRMS and RIA were compared using a Spearman correlation analysis. Results are expressed as means ± SD. A p-value of less than 5% was considered statistically significant.
Results
During method development, different procedures have been evaluated to optimize sample extraction, matrix effect, chromatographic and detection parameters. Sample preparation, extraction and chromatographic conditions have been carefully optimized for simple, rapid and practical quantitative analyse, avoiding most of matrix effects.
Chromatography and detection
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Mass spectra showing the selected precursor and product ion used for detection of HA and deuterated Histamine (HAd4) are presented in Figure 1 . 
. We hypothesize that the small peak at 4.3 min corresponds to a stereoisomer.
Chromatograms of protonated histamine (HA) and HAd4, obtained by full scan acquisition and targeted MS2 mode using a 5 ppm mass window for a human plasma sample (approximatively 20 nM)
Calibration curve and linearity
The six-point calibration curve for histamine was linear over the range of 1 to 180 nM with CVs ranging from 1.6 to 8.1%. The linearity was verified with a lack of fit test and the r² coefficient of determination was >0.99. Typical equation of calibration curve was: y = 0.9902x + 0.9735. The LLOQ was determined to be 1 nM (CV = 8.1%).
Recovery, process efficiency and matrix effect
RE was determined between 102.1 and 114.9%. In this procedure, ME was determined to be lower than 3%. Also, PE has been calculated at +11.4%, +7.8% and -0.5% respectively for 3, 30 and 150 nM QC samples.
Precision and Accuracy
Six aliquots of each QC samples (3, 30 , 150 nM) were tested in the same run to evaluate repeatability. Mean, SD, CVs, and biases are reported to be acceptable (table 2) . The inter-day evaluation of QC samples tested once a day (n=10) showed a good reproducibility (Table 3 ).
All CVs were inferior to 10% for the 3 levels (8.7, 6.1 and 3.4% for 3, 30 and 150 nM QC samples, respectively) and biases were between 0.2 and 6.1%. The precision and accuracy were in conformity with the related rules of biological sample analysis method guidelines [20] .
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Stability
Using our validated method, we assessed the stability of HA under various conditions.
Concerning the stability of stock solutions at -80°C, we did not observe any decrease in HA concentration after 1 year of storage. 
Plasma sample analysis and comparison with RIA
HA concentration of plasma samples from patients has been evaluated using our validated LCHRMS method, and compared to the concentration obtained with the gold standard RIA method. Among the 30 plasma samples tested, only 25 had a HA concentration comprised within the limit of quantification of the RIA method, as defined by the manufacturer (1 nM to 100 nM). For these samples, an excellent correlation was revealed for HA concentrations determined by the two methods (r²=0.9198, Figure 3 ). Concerning the 5 remaining samples, HA concentration of 3 of them was measured superior to 100 nM using RIA and LCHRMS, and the 2 other samples were evaluated to have a HA concentration inferior to 1 nM with both methods.
Discussion
HA quantification is useful to confirm that clinical signs of a suspected anaphylaxis reaction result from the degranulation of tissue mast cells and blood basophils. This confirmation leads to a clinical and/or biological allergic investigation in order to find the offending allergen against which the patient is sensitized, allowing thereafter avoiding a new anaphylaxis reaction by the specific eviction of the allergen, or an induction of tolerance. HA quantification with the RIA gold standard method has the advantage to be highly sensitive, but requires the use of radioactive elements that implies the formation and the follow-up of the technicians, as well as the radioactive waste management, which is dangerous and expensive. Therefore, the
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development of new methods presenting fewer disadvantages seems necessary. Methods using mass spectrometry are now commonly used in medical laboratories for quantification of drugs or metabolites. Recently, Liu J. et al described a UHPLC-MS/MS method for HA quantification in plasma of four different mammalian species including humans [21] . This method presents important advantages: low time-consuming, simple method. Unfortunately, blood samples were collected into tubes containing heparin sodium. However, it has been well-documented that heparin could bind to HA [22] ; this phenomenon could then modify the free HA concentration measured by MS in the samples. The sensitivity of the method for HA quantification seems to be lower than for other methods classically used, due to a very low signal-to-noise ratio at the LLOQ value. In addition, a statistical correlation with obtained concentrations using RIA kits had not been determined. Furthermore, five plasma samples from healthy volunteers have been tested with this method. Plasma histamine amount is known to be physiologically very low in healthy patients. Nevertheless, in the reported study, two out of these five samples showed a HA concentration superior to 10 nM (12.7 nM and 24.7 nM), concentration classically considered as the positive threshold value determining an HA release after mast cell and/or basophil degranulation. More recently, another LCMSMS method for HA quantification in rat plasma has been described by Chimalakonda K. et al [23] .
With this method, the LLOQ was determined at 156 nM. However, this value is 15 fold higher than the positive threshold usually used for clinical diagnosis. Overall, these technically advantageous methods require some complementary experiments before being recommended in medical laboratories for a diagnostic use.
In our study, High Resolution Accurate Mass LC-MS technology was chosen for HA quantification due to its high specificity and sensitivity for low molecular weight molecule quantification. Due to low amounts of HA physiologically found in plasma of healthy people,
TrisBSA was used to mimic plasma HA-free matrix. Three QC samples were prepared by fortifying TrisBSA with HA: low at 3 nM HA, weakly positive at 30 nM HA, and highly positive at 150 nM HA. Recovery, matrix effect and process efficiency have also been tested in plasmas fortified with 3, 30 and 150 nM of HA. Process efficiency was similar between fortified plasma and TrisBSA (data not shown).
Because HA concentrations over 100 nM reflect a massive mast cell and/or basophil degranulation and have no diagnostic interest, this value was chosen as the upper LOQ. The lower LOQ was determined at 1 nM, which is classically reported with other methods. For any steps of experiments, plastic containers were used, and glass surfaces were forbidden in order to avoid HA absorption, as described by Verburg and Henry [24] . Considering the extraction procedure, protein precipitation was performed using SSA. The mobile phase combined an increasing NFPA rate with an increasing flow rate in 5 min. Volatile ion -pair reagents
with long alkyl chain as NFPA are known to improve retention on ionisable polar compounds and to diminish matrix effect [25] . Moreover, in 1996,
Pearson et al showed that the use of longer alkyl chained perfluorinated carboxylic acids may be an option to solve such problems [26] . The first 4 min were necessary to elute HA and the IS. The total run time of the method was set to 10 min in order to eliminate all interferences and re-equilibrate the column for the next injection.
Between 2 injections, a 3 mL flush (75%ACN, 25% water containing 0.1% TFA) was necessary to minimized carryover.
Simplification of sample preparation steps is crucial for a routinely medical laboratory use.
However, most of HA quantification methods used for medical applications needs a derivatization step [7] 
Conclusion
In 
